A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Cardio IQ® Diabetes Risk Panel with Score
Test Code92026
CPT Codes
80061, 82947, 83036
Includes
Cardio IQ® Glucose
Cardio IQ® Hemoglobin A1c
Cardio IQ® Cholesterol, Total
Cardio IQ® HDL Cholesterol
Cardio IQ® Triglycerides
Cardio IQ® Non-HDL and Calculated Components
Cardio IQ® 8 Year Diabetes Risk
If Triglyceride is >400 mg/dL, then Cardio IQ® Direct LDL will be performed at an additional charge (CPT code(s): 83721).
Cardio IQ® Hemoglobin A1c
Cardio IQ® Cholesterol, Total
Cardio IQ® HDL Cholesterol
Cardio IQ® Triglycerides
Cardio IQ® Non-HDL and Calculated Components
Cardio IQ® 8 Year Diabetes Risk
If Triglyceride is >400 mg/dL, then Cardio IQ® Direct LDL will be performed at an additional charge (CPT code(s): 83721).
Preferred Specimen
4 mL serum collected in a Serum Separator Tube (SST®) and 1 mL whole blood collected in an EDTA (lavender-top) tube
Patient Preparation
If a cholesterol measurement is to be performed along with triglycerides, but not part of a lipid panel, then the patient should be fasting 9-12 hours prior to collection. If the cholesterol is ordered as part of a lipid panel, then a fasting sample is not required.
The assay manufacturer Beckman Coulter advises: "N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations (for the treatment of acetaminophen overdose), has been determined to interfere with assays for cholesterol, uric acid" where "NAC interference may lead to falsely low results." According to Beckman Coulter, the NAC interference should be insignificant by 12 hours after completion of the initial loading dose of an IV infusion treatment regimen consisting of an initial loading dose of 150 mg/kg administered over 1 hour, a second dose of 50 mg/kg administered over 4 hrs and a third dose of 100 mg/kg administered over 16 hrs.
Minimum Volume
2 mL serum • 0.5 mL whole blood
Instructions
See individual tests.
For risk calculations to be performed, the following patient-specific information must be provided at the time of order:
Age: Years
Gender: M (for male) or F (for female)
For risk calculations to be performed, the following patient-specific information must be provided at the time of order:
Age: Years
Gender: M (for male) or F (for female)
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
Serum
Room temperature: 48 hours
Refrigerated: 7 days
Frozen: 28 days
Whole blood
Room temperature: 7 days
Refrigerated: 7 days
Frozen: 6 months
Room temperature: 48 hours
Refrigerated: 7 days
Frozen: 28 days
Whole blood
Room temperature: 7 days
Refrigerated: 7 days
Frozen: 6 months
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis • Red-top tube (no gel) • Moderate to grossly icteric • Sodium fluoride/oxalate (grey-top) tube • Heparinized plasma
Methodology
Enzymatic • Spectrophotometry (SP)
Setup Schedule
Sets up 5 days a week.
Clinical Significance
Permit the assessment of serum glucose levels and lipid levels and the prediction of the 8-year future risk of developing diabetes mellitus in patients without diabetes mellitus.